Recent studies have showed the activation of RIPK1, RIPK3 and MLKL in the spinal cords of SOD1G93A mutant mice and in human ALS models, suggesting necroptosis may be implicated in the pathology of ALS [52, 214]. Here, MLKL is linked to amyotrophic lateral sclerosis.